Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Curr Drug Targets. 2015;16(4):284–294. doi: 10.2174/1389450115666141024152421

Fig. 4.

Fig. 4

CYLD in cardiovascular disease model. CYLD may affect any or all of these pathways to regulate the formation of vascular lesions.